LYTTON LAURENCE W 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:14 pm Purchase | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 482,430 4.990% | 64,651 (+15.47%) | Filing |
| 2022-02-14 7:44 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 417,779 6.600% | -56,621 (-11.94%) | Filing |
| 2021-02-16 11:26 am Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 474,400 9.990% | 234,138 (+97.45%) | Filing |
| 2020-06-12 4:09 pm Purchase | 2020-06-05 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 240,262 9.990% | 240,262 (New Position) | Filing |